Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous vs Intravenous Immunoglobulin for Multifocal Motor Neuropathy
NCT00268788Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Aug 2005
- Primary completion
- Feb 2008
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of subcuvia in multifocal motor neuropathy (MMN), sponsored by Aarhus University. Primary endpoint: Isokinetic muscle strength. Started Aug 2005; status: completed.
02
Drugs
subcuvia
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on NCT00268788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268788.